ArticleScientific reports2026
CDC25C downregulation suppresses HCC growth via mitochondrial stress-induced autophagy and apoptosis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cell division cyclin 25 C (CDC25C) functions as an antigen linked to hepatocellular carcinoma (HCC) and is vital for its diagnosis, treatment, and prognosis. However, the precise pathways underlying CDC25C-mediated inhibition of HCC growth remain incompletely understood. In this study, we created a CDC25C-downregulation model in AML12 and Hepa1-6 cell lines, complemented by a tumor xenograft in C57BL/6 mice. We evaluated the malignant biological behaviors and subcellular structural morphology of the CDC25C-downregulation model. Additionally, we quantified mitochondrial calcium levels, reactive oxygen species (ROS) concentrations, mitochondrial stress-related molecules, and autophagy-related proteins. Furthermore, we observed the morphological characteristics of apoptosis in CDC25C-downregulated cells, evaluated the apoptosis rate, and identified key molecules involved in the mitochondrial apoptosis pathway. Our findings indicated that the downregulation of CDC25C inhibited the proliferation, migration and invasion of HCC cells. Further analysis demonstrated that apoptosis in HCC cells was ultimately induced by CDC25C downregulation, which also triggered the mitochondrial stress response and autophagy. In contrast, normal hepatocytes exhibited the opposite effect, with the exception of autophagy. In summary, downregulation of CDC25C does not inhibit the growth of normal hepatocytes but inhibits HCC progression; its anti-HCC effect may be associated with the mitochondrial stress response as well as mitochondria-mediated autophagy and apoptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.